Publications in collaboration with researchers from Alessandro Manzoni Hospital (1)

2017

  1. Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial

    The Lancet, Vol. 389, Núm. 10084, pp. 2117-2127